CDKN2A and acute lymphoblastic leukemia: Patients with Ph+ ALL carry an average of 5–8 genomic lesions/case, and the most frequent consisted of deletions in IKZF1, PAX5 and CDKN2A/B genes, with frequent co-existence in the same patient (IKZF1plus phenotype) [19,43].